December 11, 2018

Stocks In News - USFDA

Stocks In News - USFDA

  1. Strides Pharma Science's joint venture received the US FDA's approval for its tapeworm infection treatment drug.
  2. The joint venture -- Strides Vivimed -- received approval from the US Food and Drug Administration (FDA) for its Albendazole  Tablets USP 200 mg.


No comments:

Post a Comment